Status:
UNKNOWN
Web-Mediated Risk Assessment for Endoscopic Screening of Gastric Cancer
Lead Sponsor:
State Key Laboratory of Cancer Biology
Collaborating Sponsors:
Tang-Du Hospital
Xijing Hospital
Conditions:
Gastric Cancer
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Gastric cancer is one of the most common malignancies in China. Early detection is critical for gastric cancer management. However, the diagnosis rate of patients with early gastric cancer is still lo...
Eligibility Criteria
Inclusion
- Age 18-60. 2.Signed informed consent
Exclusion
- Severe back ground disease including malignancy. 2.State after gastric surgery. 3.COPD, CHF, CRF and any disease with respiratory disturbances. 4.Deviation of the nasal septum, lack of venous access at the dorsum of the hand or any other technical problem prevents gastric acid collection or base excess evaluation.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03484949
Start Date
December 1 2017
End Date
December 1 2020
Last Update
April 18 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dake Chu
Xi'an, Shaanxi, China, 710032